Curevac Nv Stock Price History
| CVAC Stock | USD 2.77 0.11 4.14% |
Below is the normalized historical share price chart for CureVac NV extending back to August 14, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of CureVac NV stands at 2.77, as last reported on the 26th of November, with the highest price reaching 2.82 and the lowest price hitting 2.65 during the day.
If you're considering investing in CureVac Stock, it is important to understand the factors that can impact its price. CureVac NV secures Sharpe Ratio (or Efficiency) of -0.0576, which signifies that the company had a -0.0576% return per unit of risk over the last 3 months. CureVac NV exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CureVac NV's Risk Adjusted Performance of (0.05), mean deviation of 2.34, and Standard Deviation of 3.15 to double-check the risk estimate we provide.
At present, CureVac NV's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 2.2 B, whereas Total Stockholder Equity is forecasted to decline to about 447.2 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.32, whereas Price To Sales Ratio is forecasted to decline to 14.84. CureVac Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of August 2020 | 200 Day MA 3.1915 | 50 Day MA 2.8712 | Beta 2.611 |
CureVac |
Sharpe Ratio = -0.0576
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CVAC |
Estimated Market Risk
| 3.2 actual daily | 28 72% of assets are more volatile |
Expected Return
| -0.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CureVac NV is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CureVac NV by adding CureVac NV to a well-diversified portfolio.
Price Book 0.7866 | Enterprise Value Ebitda 0.3331 | Price Sales 9.0609 | Shares Float 123.5 M | Wall Street Target Price 6.8945 |
CureVac NV Stock Price History Chart
There are several ways to analyze CureVac Stock price data. The simplest method is using a basic CureVac candlestick price chart, which shows CureVac NV price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 13, 2024 | 3.44 |
| Lowest Price | November 20, 2024 | 2.49 |
CureVac NV November 26, 2024 Stock Price Synopsis
Various analyses of CureVac NV's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell CureVac Stock. It can be used to describe the percentage change in the price of CureVac NV from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of CureVac Stock.| CureVac NV Price Action Indicator | 0.09 | |
| CureVac NV Price Rate Of Daily Change | 1.04 | |
| CureVac NV Price Daily Balance Of Power | 0.65 | |
| CureVac NV Accumulation Distribution | 32,590 |
CureVac NV November 26, 2024 Stock Price Analysis
CureVac Stock Price History Data
The price series of CureVac NV for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 has a statistical range of 0.95 with a coefficient of variation of 7.64. The prices are distributed with arithmetic mean of 2.93. The median price for the last 90 days is 2.89.| Open | High | Low | Close | Volume | ||
| 11/25/2024 | 2.68 | 2.82 | 2.65 | 2.77 | 540,607 | |
| 11/22/2024 | 2.59 | 2.70 | 2.52 | 2.66 | 474,011 | |
| 11/21/2024 | 2.50 | 2.59 | 2.41 | 2.56 | 278,663 | |
| 11/20/2024 | 2.53 | 2.55 | 2.37 | 2.49 | 855,681 | |
| 11/19/2024 | 2.58 | 2.65 | 2.50 | 2.50 | 677,136 | |
| 11/18/2024 | 2.60 | 2.63 | 2.51 | 2.58 | 619,754 | |
| 11/15/2024 | 2.66 | 2.68 | 2.50 | 2.54 | 1,102,603 | |
| 11/14/2024 | 2.75 | 2.79 | 2.62 | 2.67 | 667,008 | |
| 11/13/2024 | 2.80 | 2.90 | 2.72 | 2.75 | 726,531 | |
| 11/12/2024 | 2.95 | 2.97 | 2.75 | 2.88 | 544,861 | |
| 11/11/2024 | 2.88 | 2.88 | 2.73 | 2.79 | 642,592 | |
| 11/08/2024 | 2.82 | 2.94 | 2.79 | 2.84 | 716,394 | |
| 11/07/2024 | 2.90 | 2.90 | 2.77 | 2.83 | 269,554 | |
| 11/06/2024 | 2.86 | 2.89 | 2.70 | 2.86 | 560,004 | |
| 11/05/2024 | 2.69 | 2.95 | 2.65 | 2.93 | 756,390 | |
| 11/04/2024 | 2.83 | 2.88 | 2.63 | 2.71 | 880,507 | |
| 11/01/2024 | 2.78 | 2.83 | 2.76 | 2.76 | 138,557 | |
| 10/31/2024 | 2.81 | 2.84 | 2.71 | 2.74 | 289,705 | |
| 10/30/2024 | 2.85 | 2.94 | 2.77 | 2.80 | 237,750 | |
| 10/29/2024 | 2.88 | 3.03 | 2.86 | 2.89 | 707,452 | |
| 10/28/2024 | 2.75 | 2.83 | 2.71 | 2.83 | 374,899 | |
| 10/25/2024 | 2.72 | 2.77 | 2.71 | 2.75 | 198,157 | |
| 10/24/2024 | 2.75 | 2.77 | 2.68 | 2.72 | 342,874 | |
| 10/23/2024 | 2.75 | 2.78 | 2.69 | 2.70 | 242,622 | |
| 10/22/2024 | 2.79 | 2.83 | 2.63 | 2.75 | 1,053,152 | |
| 10/21/2024 | 2.81 | 2.86 | 2.71 | 2.77 | 350,297 | |
| 10/18/2024 | 2.83 | 2.86 | 2.80 | 2.80 | 165,182 | |
| 10/17/2024 | 2.84 | 2.84 | 2.75 | 2.82 | 274,012 | |
| 10/16/2024 | 2.89 | 2.89 | 2.80 | 2.84 | 244,023 | |
| 10/15/2024 | 2.82 | 2.85 | 2.79 | 2.81 | 261,921 | |
| 10/14/2024 | 2.90 | 2.90 | 2.82 | 2.82 | 281,087 | |
| 10/11/2024 | 2.87 | 2.91 | 2.85 | 2.91 | 171,225 | |
| 10/10/2024 | 2.86 | 2.95 | 2.83 | 2.87 | 234,525 | |
| 10/09/2024 | 2.95 | 2.99 | 2.84 | 2.91 | 500,707 | |
| 10/08/2024 | 2.98 | 3.02 | 2.88 | 2.89 | 671,073 | |
| 10/07/2024 | 3.04 | 3.07 | 2.96 | 2.98 | 294,953 | |
| 10/04/2024 | 2.96 | 3.07 | 2.96 | 3.02 | 345,524 | |
| 10/03/2024 | 3.02 | 3.02 | 2.91 | 2.96 | 205,577 | |
| 10/02/2024 | 2.96 | 3.04 | 2.90 | 3.00 | 364,853 | |
| 10/01/2024 | 2.95 | 3.02 | 2.91 | 2.97 | 301,280 | |
| 09/30/2024 | 3.00 | 3.11 | 2.93 | 2.94 | 515,913 | |
| 09/27/2024 | 3.08 | 3.10 | 2.90 | 3.00 | 1,038,693 | |
| 09/26/2024 | 3.10 | 3.15 | 2.87 | 3.02 | 1,051,475 | |
| 09/25/2024 | 3.21 | 3.22 | 3.02 | 3.06 | 466,281 | |
| 09/24/2024 | 3.11 | 3.19 | 3.04 | 3.19 | 164,733 | |
| 09/23/2024 | 3.23 | 3.24 | 3.07 | 3.09 | 416,221 | |
| 09/20/2024 | 3.31 | 3.31 | 3.21 | 3.23 | 308,425 | |
| 09/19/2024 | 3.30 | 3.39 | 3.28 | 3.29 | 278,105 | |
| 09/18/2024 | 3.28 | 3.36 | 3.21 | 3.29 | 310,290 | |
| 09/17/2024 | 3.29 | 3.31 | 3.19 | 3.28 | 263,253 | |
| 09/16/2024 | 3.40 | 3.40 | 3.16 | 3.27 | 428,613 | |
| 09/13/2024 | 3.02 | 3.44 | 3.02 | 3.44 | 1,170,132 | |
| 09/12/2024 | 3.09 | 3.15 | 2.91 | 3.09 | 402,588 | |
| 09/11/2024 | 3.02 | 3.05 | 2.93 | 3.03 | 205,580 | |
| 09/10/2024 | 2.91 | 3.09 | 2.91 | 3.05 | 406,499 | |
| 09/09/2024 | 2.82 | 3.03 | 2.82 | 2.92 | 581,464 | |
| 09/06/2024 | 2.81 | 2.89 | 2.70 | 2.74 | 500,713 | |
| 09/05/2024 | 2.81 | 2.87 | 2.77 | 2.85 | 689,419 | |
| 09/04/2024 | 3.01 | 3.02 | 2.78 | 2.81 | 639,647 | |
| 09/03/2024 | 3.15 | 3.17 | 3.04 | 3.06 | 665,424 | |
| 08/30/2024 | 3.20 | 3.30 | 3.13 | 3.14 | 403,983 |
About CureVac NV Stock history
CureVac NV investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CureVac is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CureVac NV will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CureVac NV stock prices may prove useful in developing a viable investing in CureVac NV
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 220.8 M | 200 M | |
| Net Loss | -370.5 M | -352 M |
CureVac NV Quarterly Net Working Capital |
|
CureVac NV Stock Technical Analysis
CureVac NV technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
CureVac NV Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CureVac NV's price direction in advance. Along with the technical and fundamental analysis of CureVac Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CureVac to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | (0.20) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for CureVac Stock analysis
When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |